《盈警響號》謝瑞麟(00417.HK)料上財年虧損最少4,000萬元
謝瑞麟(00417.HK)發盈警,預期截至3月底止年度錄虧損不少於4,000萬元,對上財年蝕約9,000萬元。
公司指,新型冠狀病毒影響了全球經濟,減弱國內外需求,而集團在所有營運地區的銷售表現,自回顧財政年度開始以來都受到極大影響。內地銷售自2020年5月起逐漸回穩至疫情前水平,而香港的銷售跌幅亦從2020年9月起開始收窄,但各項折扣促銷活動降低了利潤率,減慢了復甦速度。
各種自2019年8月起為減少開支而實行的成本節省措施(包括與業主協商租金、重組商店網絡等)、簡化組織結構後全年員工成本的縮減和政府的補貼亦為減低虧損作出了貢獻。董事會認為,集團正在沿正軌健康發展,勢頭良好,財務狀況亦保持穩健。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.